Home  »  Finance   »  Forecast: Radius Health Inc. (NASDAQ: RDUS) Stock ...

Forecast: Radius Health Inc. (NASDAQ: RDUS) Stock Will Go Up 4.58% In 2022

Radius Health Inc. (NASDAQ:RDUS) price closed higher on Friday, July 01, jumping 1.06% above its previous close.

A look at the daily price movement shows that the last close reads $10.37, with intraday deals fluctuated between $10.23 and $10.49. The company’s 5Y monthly beta was ticking 0.93. Taking into account the 52-week price action we note that the stock hit a 52-week high of $23.00 and 52-week low of $4.97. The stock added 68.76% on its value in the past month.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Radius Health Inc., which has a market valuation of $493.61 million, is expected to release its quarterly earnings report Feb 23, 2022 – Feb 28, 2022. Analysts tracking RDUS have forecast the quarterly EPS to grow by 0.05 per share this quarter, while the same analysts predict the annual EPS to hit -$0.29 for the year 2022 and up to $0.31 for 2023. In this case, analysts estimate an annual EPS growth of 80.50% for the year and 206.90% for the next year.

On average, analysts have forecast the company’s revenue for the quarter will hit $67.21 million, with the likely lows of $56.39 million and highs of $83.46 million. Staying with the analyst view, there is a consensus estimate of $241.7 million for the company’s annual revenue in 2022. Per this projection, the revenue is forecast to grow 5.10% above that which the company brought in 2022.

Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with 4 upward and no downward reviews. On the technical perspective front, indicators give RDUS a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.

The overview shows that RDUS’s price is at present 25.35% off the SMA20 and 46.21% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 70.90, with weekly volatility standing at 2.92%. The indicator jumps to 7.82% when calculated based on the past 30 days. Radius Health Inc. (NASDAQ:RDUS)’s beta value is holding at 0.55, while the average true range (ATR) indicator is currently reading 0.60. Considering analysts have assigned the stock a price target range of $10.00-$10.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $10.00. Based on this estimate, we see that current price is roughly 4.58% off the estimated low and 4.58% off the forecast high. Investors will no doubt be excited to see the share price rise to $10.00, which is the median consensus price, and at that level RDUS would be 4.58% from current price.

Turning out attention to how the Radius Health Inc. stock has performed in comparison to its peers in the industry, here’s what we find: RDUS’s stock is 1.06% on the day and -42.58% in the past 12 months, while Eli Lilly and Company (LLY) traded 0.15% in the last session and was positioned 40.49% up on its price 12 months ago. Another comparison is with Novartis AG (NVS) whose stock price was down -0.20% in the last trading session, and has flourished -7.95% over the past year. Also, Charles River Laboratories International Inc. (CRL) showed up trend of 2.27% while its price kept floating at -41.28% over the past year. Elsewhere in the market, the S&P 500 Index has rallied 1.06% in last trading session, with the Dow Jones Industrial also saw a positive session on the day with 1.05%.

An analysis of the Radius Health Inc. (NASDAQ:RDUS) stock in terms of its daily trading volume indicates that the 3-month average is 1.14 million. However, this figure increases on the past 10-day timeline to an average of 2.97 million.

Current records show that the company has 47.44M in outstanding shares. The insiders’ percentage holdings are 1.00% of outstanding shares. The stats also highlight that short interest as of Apr 28, 2022, stood at 9.16 million shares, which puts the short ratio at the time at 16.11. From this we can glean that short interest is 19.25% of company’s current outstanding shares. Notably, we see that shares short in April rose slightly given the previous month’s figure stood at 8.99 million. But the 51.45% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]